IL2 and neoplasm: However, IL-2–induced, T-bethi Tc1 cells have a short lifespan in the suppressive tumor microenvironment (TME) after ACT (15, 16), and our previous studies showed that adoptively transferred tumor-specific Tc9 cells elicit a stronger antitumor response against advanced tumors than Tc1 cells (5, 17).